TRIB

Trinity Biotech
TRIB

Overview Fund Activity

23 hedge funds and large institutions have $2.3M invested in Trinity Biotech in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
+4
Holders Change %
+21.05%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
1
Reduced
3
Closed
5
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
+$11K

Top Buyers

1
HAIM
Hunter Associates Investment Management
Pennsylvania
$334K
2
Geode Capital Management
Geode Capital Management
Massachusetts
$15.6K
3
GI
GAMMA Investing
California
$11.7K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$11K
5
UBS Group
UBS Group
Switzerland
$9.35K

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
$166K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
$0
3
HF
HRT Financial
New York
$0
4
VF
Virtu Financial
New York
$0
5
Citadel Advisors
Citadel Advisors
Florida
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
VF
26
Virtu Financial
New York
– -$20K -17,804 Closed
Citadel Advisors
27
Citadel Advisors
Florida
– -$15.6K -14,151 Closed
SIC
28
SJS Investment Consulting
Ohio
– -$2.2K -2,000 Closed
1
2